BUSINESS● LOWSep 15 · Sep 15, 2026, 6:30 AM
GSK expands myeloma pipeline in deal worth up to $750M
Seeking Alpha Tech · global
GSK is expanding its myeloma pipeline through a deal valued at up to $750 million. This business transaction indicates strategic growth in the pharmaceutical company's cancer research and development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS32m agoCanadian National Railway Non-GAAP EPS of C$2.16 beats by C$0.08, revenue of C$4.77B beats by C$120MSeeking Alpha TechBUSINESS32m agoExxon rises after posting Q3 earnings topper on record refining haulSeeking Alpha Tech